Literature DB >> 10261424

Quality, cost, and clinical decisions.

A Donabedian.   

Abstract

Clinical decisions require determining the objectives of care as well as selecting and implementing a strategy of care. At the very least the optimal strategy balances the expected benefit and harm from technical interventions. Health care practitioners tend to specify optimal strategies based on what they consider to be best for patients, without regard to monetary cost. This is an absolutist definition of quality. Individuals may place different valuations on the outcomes, are concerned with the monetary costs to themselves, and are particularly sensitive to the attributes of the interpersonal relationship with the practitioners. Including all of these leads to an individualized definition of the quality of care. But this specification of quality may be in conflict with a social definition of quality, which takes into account social as well as individual monetary costs, externalities, and the social distribution of quality. The health care professions may respond to the conflict in several ways, which are described in this article as evasion, rejection and confrontation, anticipation, advocacy, active complicity, passive complicity, and ambiguous adaptations.

Entities:  

Mesh:

Year:  1983        PMID: 10261424     DOI: 10.1177/0002716283468001013

Source DB:  PubMed          Journal:  Ann Am Acad Pol Soc Sci        ISSN: 0002-7162


  3 in total

Review 1.  Myocardial single-photon emission computed tomographic quality assurance.

Authors:  J M Baron; P Chouraqui
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

2.  The effect of information technology on hospital performance.

Authors:  Cynthia Williams; Yara Asi; Amanda Raffenaud; Matt Bagwell; Ibrahim Zeini
Journal:  Health Care Manag Sci       Date:  2015-05-28

3.  The effects of a low-cost intervention program on hospital costs.

Authors:  J E Billi; L Duran-Arenas; C G Wise; A M Bernard; M McQuillan; J K Stross
Journal:  J Gen Intern Med       Date:  1992 Jul-Aug       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.